Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine on Postoperative Delirium in Elderly Thoracoscopic Surgery
NCT07569614Completed
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Apr 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in postoperative delirium (POD) (3 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoint: Incidence of postoperative delirium. Started Apr 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07569614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07569614.